Filed 27d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateMay 8, 2026
BRISTOL MYERS SQUIBB CO UNSOLICITED
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 328
Filed 27d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Vertex Pharmaceuticals
VRTX
$15K+
Trade dateMay 8, 2026
Filed 27d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
AbbVie
ABBV
$50K-$100K
+5.1% vs S&P 500
Trade dateMay 8, 2026
Filed 27d ago· May 8, 2026
24 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
Trade dateApr 14, 2026
Filed 1mo ago· Apr 13, 2026
18 days to disclose
Thomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.9% vs S&P 500
Trade dateMar 26, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 7, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
−0.9% vs S&P 500
Trade dateMar 13, 2026
Filed 2mo ago· Mar 9, 2026
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−36.0% vs S&P 500
Trade dateFeb 10, 2026
Filed 3mo ago· Mar 6, 2026
8 days to disclose
David J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+8.9% vs S&P 500
Trade dateFeb 26, 2026
Filed 3mo ago· Mar 6, 2026
8 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−5.7% vs S&P 500
Trade dateFeb 26, 2026
Filed 3mo ago· Feb 20, 2026
11 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−5.0% vs S&P 500
Trade dateFeb 9, 2026
Filed 3mo ago· Feb 19, 2026
27 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−5.7% vs S&P 500
Trade dateJan 23, 2026
⚑ Pharmaceutical
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
-
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−4.6% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Amgen
AMGN
$1K-$15K
+3.8% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day window
Julia Letlow
RHouseLouisiana-05
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−9.1% vs S&P 500
Trade dateOct 23, 2024
-
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−33.4% vs S&P 500
Trade dateDec 19, 2025
Filed 5mo ago· Dec 19, 2025
9 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Eli Lilly
LLY
$1K-$15K
−2.4% vs S&P 500
Trade dateDec 10, 2025
Filed 5mo ago· Dec 19, 2025
29 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−1.9% vs S&P 500
Trade dateNov 20, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−32.7% vs S&P 500
Trade dateNov 18, 2025
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Dec 5, 2025
25 days to disclose
Markwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$15K-$50K
+0.8% vs S&P 500
Trade dateNov 10, 2025
Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
United Therapeutics
UTHR
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
Common Stock
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
United Therapeutics
UTHR
$1K-$15K
+26.2% vs S&P 500
Trade dateOct 30, 2025
Common Stock
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
United Therapeutics
UTHR
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
Common Stock
⚑ Pharmaceutical
Filed 7mo ago· Oct 28, 2025
4 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+11.1% vs S&P 500
Trade dateOct 24, 2025
Filed 7mo ago· Oct 20, 2025
5 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Novo Nordisk
NVO
$1K-$15K
−23.5% vs S&P 500
Trade dateOct 15, 2025
Filed 7mo ago· Oct 16, 2025
10 days to disclose
Rick Larsen
DHouseWashington-02
↓sold
Zoetis
ZTS
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 6, 2025
Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
AstraZeneca
AZN
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Depositary Shares
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Merck
MRK
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Stock
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Elanco Animal Health
ELAN
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Common Stock
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Eli Lilly
LLY
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Gilead Sciences
GILD
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
GSK PLC
GSK
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 8mo ago· Sep 27, 2025
16 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+10.1% vs S&P 500
Trade dateSep 11, 2025
Filed 8mo ago· Sep 12, 2025
36 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
BioNTech
BNTX
$1K-$15K
+15.1% vs S&P 500
Trade dateAug 7, 2025
Shares
Filed 8mo ago· Sep 12, 2025
38 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
+12.1% vs S&P 500
Trade dateAug 5, 2025
Filed 8mo ago· Sep 12, 2025
39 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Zoetis
ZTS
$1K-$15K
+11.7% vs S&P 500
Trade dateAug 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
129 days to disclose · 84 past 45-day windowVal T. Hoyle
DHouseOregon-04
↓sold
Eli Lilly
LLY
$1K-$15K
+10.6% vs S&P 500
Trade dateMay 6, 2025
Filed 8mo ago· Sep 12, 2025
298 days to disclose · 253 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
GSK PLC
GSK
$1K-$15K
+45.4% vs S&P 500
Trade dateNov 18, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
AstraZeneca
AZN
$1K-$15K
+42.9% vs S&P 500
Trade dateOct 29, 2024
Depositary Shares
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Eli Lilly
LLY
$1K-$15K
+32.3% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.5% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Gilead Sciences
GILD
$1K-$15K
+37.9% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Merck
MRK
$1K-$15K
+12.2% vs S&P 500
Trade dateOct 29, 2024
Stock
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Novo Nordisk
NVO
$1K-$15K
−57.6% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+4.1% vs S&P 500
Trade dateOct 29, 2024
Common Stock
Filed 9mo ago· Sep 2, 2025
19 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$1K-$15K
+43.4% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
19 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Eli Lilly
LLY
$15K-$50K
+43.4% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
26 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−2.9% vs S&P 500
Trade dateAug 7, 2025
-
Filed 9mo ago· Aug 29, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Novo Nordisk
NVO
$1K-$15K
−27.3% vs S&P 500
Trade dateAug 28, 2025
Filed 9mo ago· Aug 29, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Merck
MRK
$1K-$15K
+27.6% vs S&P 500
Trade dateAug 28, 2025
Stock
Filed 9mo ago· Aug 20, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Novo Nordisk
NVO
$15K-$50K
−25.1% vs S&P 500
Trade dateAug 19, 2025
Filed 9mo ago· Aug 20, 2025
20 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+13.9% vs S&P 500
Trade dateJul 31, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 20, 2025
40 days to disclose
Ritchie Torres
DHouseNew York-15
↓sold
AbbVie
ABBV
$1K-$15K
+9.9% vs S&P 500
Trade dateJul 11, 2025
Filed 9mo ago· Aug 20, 2025
40 days to discloseRitchie Torres
DHouseNew York-15
↓sold
Merck
MRK
$1K-$15K
+9.9% vs S&P 500
Trade dateJul 11, 2025
Stock
Filed 9mo ago· Aug 20, 2025
40 days to discloseRitchie Torres
DHouseNew York-15
↓sold
R
RHHBY
$1K-$15K
+9.9% vs S&P 500
Trade dateJul 11, 2025
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day windowRitchie Torres
DHouseNew York-15
↑bought
Merck
MRK
$1K-$15K
−25.8% vs S&P 500
Trade dateSep 26, 2024
Stock
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day windowRitchie Torres
DHouseNew York-15
↑bought
AbbVie
ABBV
$1K-$15K
−21.2% vs S&P 500
Trade dateSep 26, 2024
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day windowRitchie Torres
DHouseNew York-15
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+16.2% vs S&P 500
Trade dateSep 26, 2024
Filed 9mo ago· Aug 15, 2025
11 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
−2.3% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Zoetis
ZTS
$1K-$15K
−60.7% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
63 days to disclose · 18 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+9.4% vs S&P 500
Trade dateJun 11, 2025
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
63 days to disclose · 18 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
United Therapeutics
UTHR
$1K-$15K
+102.4% vs S&P 500
Trade dateJun 11, 2025
Common Stock
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
64 days to disclose · 19 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+9.5% vs S&P 500
Trade dateJun 10, 2025
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
210 days to disclose · 165 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Zoetis
ZTS
$1K-$15K
+5.6% vs S&P 500
Trade dateJan 15, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
245 days to disclose · 200 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Zoetis
ZTS
$1K-$15K
−61.4% vs S&P 500
Trade dateDec 11, 2024
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
245 days to disclose · 200 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−14.5% vs S&P 500
Trade dateDec 11, 2024
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 12, 2025
496 days to disclose · 451 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$1K-$15K
+65.7% vs S&P 500
Trade dateApr 3, 2024
Filed 9mo ago· Aug 12, 2025
586 days to disclose · 541 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−67.3% vs S&P 500
Trade dateJan 4, 2024
Filed 9mo ago· Aug 12, 2025
586 days to disclose · 541 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$1K-$15K
−67.3% vs S&P 500
Trade dateJan 4, 2024
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Vertex Pharmaceuticals
VRTX
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
-
Filed 11mo ago· Jun 22, 2025
41 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Zoetis
ZTS
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 18, 2025
12 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+9.6% vs S&P 500
Trade dateJun 6, 2025
Filed 11mo ago· Jun 11, 2025
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Zoetis
ZTS
$50K-$100K
−65.0% vs S&P 500
Trade dateMay 13, 2025
Filed 1.0y ago· May 31, 2025
16 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Zoetis
ZTS
$1K-$15K
−66.2% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 1.0y ago· May 19, 2025
5 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+10.1% vs S&P 500
Trade dateMay 14, 2025
Filed 1.0y ago· May 19, 2025
5 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Eli Lilly
LLY
$1K-$15K
+34.2% vs S&P 500
Trade dateMay 14, 2025
Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 15, 2025
30 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 15, 2025
30 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
41 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateApr 3, 2025
Intra-Cellular Therapies
Filed 1.1y ago· May 14, 2025
43 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Zoetis
ZTS
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· May 12, 2025
34 days to discloseMarkwayne Mullin
RSenateOklahoma
↓sold
Zoetis
ZTS
$15K-$50K
+11.7% vs S&P 500
Trade dateApr 8, 2025
Filed 1.1y ago· May 8, 2025
21 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
Zoetis
ZTS
$15K-$50K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 8, 2025
31 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Zoetis
ZTS
$15K-$50K
−59.3% vs S&P 500
Trade dateApr 7, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+41.7% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+23.9% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Merck
MRK
$1K-$15K
+29.6% vs S&P 500
Trade dateMay 5, 2025
Stock
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
+2.5% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+10.0% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Eli Lilly
LLY
$1K-$15K
+22.7% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Gilead Sciences
GILD
$1K-$15K
+23.9% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
22 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Sarepta Therapeutics
SRPT
$1K-$15K
+7.2% vs S&P 500
Trade dateApr 14, 2025
Stock
Filed 1.1y ago· May 6, 2025
33 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateApr 3, 2025
Intra-Cellular Therapies
Filed 1.1y ago· Apr 28, 2025
20 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Zoetis
ZTS
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 23, 2025
30 days to disclose
George Whitesides
DHouseCalifornia-27
↓sold
Theravance Biopharma
TBPH
$15K-$50K
+2.2% vs S&P 500
Trade dateMar 24, 2025
Ordinary Shares
Filed 1.1y ago· Apr 14, 2025
25 days to disclose
Byron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 27d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Bristol-Myers Squibb BMY BRISTOL MYERS SQUIBB CO UNSOLICITED | May 8, 2026 | price pending | $15K-$50K midpoint $32.5K |
May 8, 2026 27d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Vertex Pharmaceuticals VRTX | May 8, 2026 | price pending | $15K+ midpoint $15K |
May 8, 2026 27d ago | Donald J. Trump RPOTUSFlorida | ↑bought | AbbVie ABBV | May 8, 2026 | Good buy·+$4.8K+6.3% +5.1% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2026 27d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Apr 14, 2026 24 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Apr 13, 2026 1mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Mar 26, 2026 18 days to disclose | Flat·+0.0% +1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Feb 10, 2026 27 days to disclose | Bad buy·−$3.2K-40.4% −36.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Feb 26, 2026 8 days to disclose | Good buy·+$262+3.3% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Feb 26, 2026 8 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 20, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Feb 9, 2026 11 days to disclose | Flat·+0.0% −5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 19, 2026 3mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jan 23, 2026 27 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Vertex Pharmaceuticals VRTX - | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Jan 16, 2026 17 days to disclose | Flat·+0.0% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Amgen AMGN | Jan 16, 2026 17 days to disclose | Bad buy·−$69-0.9% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Vertex Pharmaceuticals VRTX - | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$826-10.3% −9.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Dec 19, 2025 24 days to disclose | Bad buy·−$3K-37.6% −33.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Dec 10, 2025 9 days to disclose | Flat·+0.0% −2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 20, 2025 29 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Nov 18, 2025 27 days to disclose | Bad buy·−$2.8K-35.4% −32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Nov 10, 2025 25 days to disclose | Flat·+0.0% +0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | United Therapeutics UTHR Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | United Therapeutics UTHR Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$2.3K+29.1% +26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | United Therapeutics UTHR Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 28, 2025 7mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Oct 24, 2025 4 days to disclose | Good buy·+$1K+12.8% +11.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2025 7mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Oct 15, 2025 5 days to disclose | Bad buy·−$1.5K-19.3% −23.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 16, 2025 7mo ago | Rick Larsen DHouseWashington-02 | ↓sold | Zoetis ZTS | Oct 6, 2025 10 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | AstraZeneca AZN Depositary Shares | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Merck MRK Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Elanco Animal Health ELAN Common Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Johnson & Johnson JNJ | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Gilead Sciences GILD | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | GSK PLC GSK | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 27, 2025 8mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Sep 11, 2025 16 days to disclose | Good buy·+$1.3K+16.4% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | BioNTech BNTX Shares | Aug 7, 2025 36 days to disclose | Flat·+0.0% +15.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Aug 5, 2025 38 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | May 6, 2025 129 days to disclose · 84 past 45-day window | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | GSK PLC GSK | Nov 18, 2024 298 days to disclose · 253 past 45-day window | Good buy·+$4K+50.0% +45.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | AstraZeneca AZN Depositary Shares | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.4K+42.9% +42.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Eli Lilly LLY | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$2.6K+32.4% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Johnson & Johnson JNJ | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.8K+47.6% +47.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Gilead Sciences GILD | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3K+38.0% +37.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Merck MRK Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$980+12.2% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Novo Nordisk NVO | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$4.6K-57.5% −57.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$333+4.2% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$4.3K+54.2% +43.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$17.6K+54.2% +43.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Vertex Pharmaceuticals VRTX - | Aug 7, 2025 26 days to disclose | Good buy·+$977+12.2% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 29, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Aug 28, 2025 1 day to disclose | Bad buy·−$1.5K-18.4% −27.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 29, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | Aug 28, 2025 1 day to disclose | Good buy·+$2.9K+36.5% +27.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Aug 19, 2025 1 day to disclose | Bad buy·−$5.4K-16.5% −25.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2025 9mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jul 31, 2025 20 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↓sold | AbbVie ABBV | Jul 11, 2025 40 days to disclose | Flat·+0.0% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↓sold | Merck MRK Stock | Jul 11, 2025 40 days to disclose | Flat·+0.0% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↓sold | R RHHBY | Jul 11, 2025 40 days to disclose | Flat·+0.0% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | Merck MRK Stock | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Bad buy·−$84-1.1% −25.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | AbbVie ABBV | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Good buy·+$284+3.5% −21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | Johnson & Johnson JNJ | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Good buy·+$3.3K+41.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Aug 4, 2025 11 days to disclose | Good buy·+$749+9.4% −2.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Zoetis ZTS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Bad buy·−$4K-49.5% −60.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | United Therapeutics UTHR Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Good buy·+$8.9K+111.8% +102.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 10, 2025 64 days to disclose · 19 past 45-day window | Flat·+0.0% +9.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jan 15, 2025 210 days to disclose · 165 past 45-day window | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Zoetis ZTS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Bad buy·−$4.6K-56.9% −61.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Bad buy·−$799-10.0% −14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Apr 3, 2024 496 days to disclose · 451 past 45-day window | Smart sell·+$2.3K+28.3% +65.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Jan 4, 2024 586 days to disclose · 541 past 45-day window | Bad buy·−$4.9K-60.7% −67.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | Jan 4, 2024 586 days to disclose · 541 past 45-day window | Bad buy·−$4.9K-60.7% −67.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Vertex Pharmaceuticals VRTX - | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Zoetis ZTS | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 18, 2025 11mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | Jun 6, 2025 12 days to disclose | Good buy·+$1.6K+20.1% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Zoetis ZTS | May 13, 2025 29 days to disclose | Bad buy·−$39.3K-52.4% −65.0% vs S&P 500 | $50K-$100K midpoint $75K |
May 31, 2025 1.0y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Zoetis ZTS ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 16 days to disclose | Bad buy·−$4.2K-52.4% −66.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2025 1.0y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | May 14, 2025 5 days to disclose | Good buy·+$2K+25.4% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2025 1.0y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 14, 2025 5 days to disclose | Good buy·+$4K+49.5% +34.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Apr 3, 2025 41 days to disclose | price pending | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Zoetis ZTS | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | Markwayne Mullin RSenateOklahoma | ↓sold | Zoetis ZTS | Apr 8, 2025 34 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Zoetis ZTS | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Zoetis ZTS | Apr 7, 2025 31 days to disclose | Bad buy·−$15.9K-48.8% −59.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | May 5, 2025 1 day to disclose | Good buy·+$3.9K+49.2% +41.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | May 5, 2025 1 day to disclose | Good buy·+$2.5K+31.4% +23.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | May 5, 2025 1 day to disclose | Good buy·+$3K+37.1% +29.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | May 5, 2025 1 day to disclose | Good buy·+$799+10.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | May 5, 2025 1 day to disclose | Good buy·+$1.4K+17.5% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 5, 2025 1 day to disclose | Good buy·+$2.4K+30.2% +22.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | May 5, 2025 1 day to disclose | Good buy·+$2.5K+31.4% +23.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Sarepta Therapeutics SRPT Stock | Apr 14, 2025 22 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Apr 3, 2025 33 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Zoetis ZTS ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | George Whitesides DHouseCalifornia-27 | ↓sold | Theravance Biopharma TBPH Ordinary Shares | Mar 24, 2025 30 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |